Brought to you by 
Nexstim closes €15.3mm dual listing in Finland and Sweden
13 Nov 2014
Executive Summary
Neuromodulation company Nexstim PLC closed a €15.3mm ($19.1mm) IPO in a dual listing of 2.4mm shares at €6.35 on Nasdaq OMX First North Finland and Nasdaq OMX First North Sweden (the company listed 1.2mm shares on each exchange). Institutional investors bought the majority (95%) of the IPO shares, and retail backers the rest. The company filed for the offering last month, planning to sell 2.9mm shares for €8.70-9.80, then later increased the amount of stock (3.9mm) and decreased the price range (€6.35-6.40).
Deal Industry
- Medical Devices
-
Medical Devices
- Monitoring Equipment & Devices
-
Diagnostic Imaging Equipment & Supplies
- MRI, NMR
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Nexstim closes €15.3mm dual listing in Finland and Sweden
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice